Page 1466 - Small Animal Internal Medicine, 6th Edition
P. 1466

1438   PART XIV   Infectious Diseases



                   TABLE 92.1
  VetBooks.ir  Antibiotics Used for the Treatment of Bacterial Infections in Dogs and Cats and General Dosing Guidelines*—cont’d



             DRUG                      MECHANISM               SPECIES  DOSAGE                   ROUTE OF
                                                                                                 ADMINISTRATION
             Ampicillin sulbactam                             B         20 mg/kg, q8-12h         IV, IM
             Ampicillin sodium                                B         20-30 mg/kg, q8-12h      SC, IM, IV
             Oxacillin                                        B         22-40 mg/kg, q8h         PO
             Penicillin G                                     B         25,000- 40,000 U/kg,     IV
                                                                          q12h
             Ticarcillin and clavulanate                      D         20-50 mg/kg, q6-8h       IM, IV
             Quinolones                Nucleic acid inhibition
             Enrofloxacin                                     D         5-20 mg/kg, q12-24h      PO, IM, SC, IV
                                                               C        5.0 mg/kg, q24h          PO, IM, IV
             Marbofloxacin                                    B         2.75-5.5 mg/kg, q24h     PO
             Orbifloxacin                                     D         2.5-7.5 mg/kg, q24h      PO
                                                               C        7.5 mg/kg, q24h          PO
             Pradofloxacin                                    D         5.0 mg/kg, q24h          PO
                                                               C        7.5 mg/kg, q24hr         PO
             Potentiated sulfas        Intermediary metabolism
                                         inhibition
             Ormetoprim-sulfadimethoxine                      D         27.5 mg/kg, q24h         PO
             Trimethoprim-sulfadiazine                        B         15 mg/kg, q12h           PO
             Tetracyclines             Protein synthesis inhibition
             Doxycycline                                      B         5 mg/kg, q12h OR         PO, IV
                                                                          10 mg/kg, q24h
             Minocycline                                      D         5-10 mg/kg, q12h         PO
                                                               C        50 mg/cat, q24h          PO
             Tetracycline                                     B         22 mg/kg, q8-12h         PO

            B, Dog and cat; C, cat; D, dog; IM, Intramuscular; IV, intravenous; PO, oral; SC, subcutaneous.
            *The dose ranges and intervals in this table are general. Please see appropriate sections to determine the optimal dose for specific syndromes
            or infections.
            † For parenterally administered aminoglycosides, giving the total daily dose at one time may lessen the potential for renal toxicity.
            § The maximal total daily dose should be 50 mg/kg.


              The following is a brief discussion of the empirical anti-  potential, such as the mucous membranes of the oral cavity
            microbial choices for treatment of infections of various body   and vagina. The origin of most anaerobic infections is the
            systems or types of infections. The reader is referred to indi-  animal’s own flora. Anaerobic infections are potentiated by
            vidual chapters for further information concerning adjunct   poor blood supply, tissue necrosis, prior infection, or immu-
            treatments.                                          nosuppression. Anaerobic bacteria produce a number of
                                                                 enzymes and factors that induce tissue injury and promote
                                                                 colonization. Most infections involving anaerobes usually
            ANAEROBIC INFECTIONS                                 have coexisting aerobic bacterial infection, which should be
                                                                 considered when selecting antimicrobial agents.
            The anaerobic bacteria with the most clinical relevance in   Anaerobic infections are commonly associated with
            dog and cats are  Actinomyces spp.,  Bacteroides spp.,  Clos-  infections of the oropharynx, central nervous system (CNS),
            tridium spp., Eubacterium spp., Fusobacterium spp., Pepto-  subcutaneous space, musculoskeletal system, GI tract, liver,
            streptococcus spp., and Porphyromonas spp. Actinomyces is a   and female genital tract, and can be associated with clinical
            facultative anaerobe; the other organisms are obligate anaer-  disease  in  animals  with  aspiration  pneumonia  or  consoli-
            obes, which cannot use oxygen metabolically and die in its   dated lung lobes. Dogs and cats with gingivitis or stomatitis,
            presence. Anaerobic bacteria are part of the normal flora in   rhinitis, retrobulbar abscesses, retropharyngeal abscesses,
            areas with low oxygen tension and low oxygen-reduction   pyothorax, otitis media or interna, CNS infection, bite
   1461   1462   1463   1464   1465   1466   1467   1468   1469   1470   1471